Announcements
- EUROBIO SCIENTIFIC SIGNS AN AGREEMENT TO ACQUIRE GENE EXPRESSION TEST FOR BREAST CANCER ENDOPREDICT®
- EUROBIO SCIENTIFIC SIGNE UN ACCORD POUR L'ACQUISITION DU TEST D'EXPRESSION GÉNIQUE POUR LE CANCER DU SEIN ENDOPREDICT®
- Eurobio Scientific : mise à disposition du rapport financier annuel 2023
- Eurobio Scientific : Rapport Financier Annuel 2023
- EUROBIO SCIENTIFIC: 2023 ANNUAL RESULTS
- EUROBIO SCIENTIFIC: RESULTAT ANNUEL 2023
- Eurobio Scientific: FISCAL YEAR 2023, STRATEGIC TRANSFORMATION OF THE GROUP
- Eurobio Scientific : EXERCICE 2023, CONFIRMATION DE LA TRANSFORMATION STRATEGIQUE
- EUROBIO SCIENTIFIC CONFIRME SON ELIGIBILITE AU DISPOSITIF PEA-PME
- Eurobio Scientific : BILAN SEMESTRIEL S2 DU CONTRAT DE LIQUIDITE
More ▼
Key statistics
On Thursday, Eurobio Scientific SA (E8TN:DEU) closed at 14.44, 19.14% above the 52 week low of 12.12 set on Oct 10, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 14.66 |
---|---|
High | 14.66 |
Low | 14.44 |
Bid | 14.58 |
Offer | 14.84 |
Previous close | 14.50 |
Average volume | 0.20 |
---|---|
Shares outstanding | 10.25m |
Free float | 6.04m |
P/E (TTM) | 34.02 |
Market cap | 150.45m EUR |
EPS (TTM) | 0.4315 EUR |
Data delayed at least 15 minutes, as of Jun 06 2024.
More ▼